Polymorphisms of T- cell leukemia 1A gene loci are not related to the development of adjuvant letrozole-induced adverse events in breast cancer

Letrozole, an aromatase inhibitor (AI), is the first-line adjuvant drug for treating hormone receptor-positive (HR+) breast cancer in postmenopausal women. However, harmful adverse events (AEs) and significant differences in drug response among individuals remain a significant problem in clinical ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Umamaheswaran, Gurusamy, Kadambari, Dharanipragada, Muthuvel, Suresh Kumar, Kumar, Naveena A. N., Dubashi, Biswajit, Aibor Dkhar, Steven, Adithan, Chandrasekaran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990231/
https://www.ncbi.nlm.nih.gov/pubmed/33760860
http://dx.doi.org/10.1371/journal.pone.0247989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990231/
https://www.ncbi.nlm.nih.gov/pubmed/33760860
http://dx.doi.org/10.1371/journal.pone.0247989

Ejemplares similares